USA Script Helpers

Diabetes management often requires the use of insulin to maintain blood glucose levels within the target range. With various types of insulin available on the market, choosing the right one can be a daunting task. Two commonly prescribed insulins are Tresiba and Humulin. This article delves into the specifics of these insulins, comparing their uses, benefits, side effects, and suitability for different patients.

Understanding Diabetes and Insulin

Before exploring Tresiba and Humulin, it’s important to understand the role of insulin in managing diabetes. Diabetes is a chronic condition characterized by high blood glucose levels. The pancreas produces insulin, a hormone that helps glucose enter cells to be used for energy. In diabetes, the body either doesn’t produce enough insulin (Type 1 diabetes) or becomes resistant to insulin’s effects (Type 2 diabetes).

Insulin therapy is crucial for managing both types of diabetes. It helps lower blood glucose levels and prevents complications such as nerve damage, kidney disease, and cardiovascular problems. Insulins are categorized based on how quickly they work, when they peak, and how long they last. This categorization includes rapid-acting, short-acting, intermediate-acting, long-acting, and ultra-long-acting insulins.

Tresiba (Insulin Degludec)

Tresiba is a long-acting insulin that provides a steady level of insulin over an extended period. It is known for its flexibility and extended duration of action.

Pharmacokinetics:

• Onset: Tresiba begins to work within 30 to 90 minutes after injection.
• Peak: It does not have a pronounced peak, providing a steady effect.
• Duration: Tresiba can last up to 42 hours, allowing for once-daily dosing at any time of day.

Mechanism of Action:

Tresiba works by mimicking the natural pattern of insulin secretion in the body. It provides a basal insulin level to manage blood glucose levels between meals and overnight.

Benefits:

• Flexibility: Tresiba’s long duration allows for flexible dosing times, which can be beneficial for patients with irregular schedules.
• Steady Blood Sugar Control: The lack of a pronounced peak helps reduce the risk of hypoglycemia (low blood sugar).
• Convenience: Once-daily dosing simplifies the insulin regimen for many patients.

Side Effects:

Common side effects include hypoglycemia, allergic reactions, injection site reactions, and weight gain. Rare but serious side effects may include severe hypoglycemia and hypersensitivity reactions.

Suitability:

Tresiba is suitable for both Type 1 and Type 2 diabetes patients who require a long-acting insulin to manage their blood glucose levels. It is particularly beneficial for those who need flexibility in their dosing schedule.

Humulin (Insulin Human)

Humulin is a brand of insulin that includes different formulations: Humulin R (regular insulin), Humulin N (NPH insulin), and Humulin 70/30 (a premixed insulin). Each formulation serves different purposes and has unique characteristics.

Humulin R (Regular Insulin):

• Pharmacokinetics:
  • Onset: Begins to work within 30 minutes after injection.
  • Peak: Peaks in 2 to 4 hours.
  • Duration: Lasts up to 6 to 8 hours.
• Uses: Humulin R is used to control blood glucose levels during meals. It is typically injected 30 minutes before eating.
• Benefits: It provides reliable mealtime glucose control and can be used in a sliding scale regimen.
• Side Effects: Common side effects include hypoglycemia, allergic reactions, and injection site reactions.

Humulin N (NPH Insulin):

• Pharmacokinetics:
  • Onset: Begins to work within 1 to 2 hours after injection.
  • Peak: Peaks in 4 to 12 hours.
  • Duration: Lasts up to 18 hours.
• Uses: Humulin N is an intermediate-acting insulin used to provide basal insulin coverage. It is typically injected once or twice daily.
• Benefits: It provides prolonged insulin coverage and can be combined with rapid- or short-acting insulins.
• Side Effects: Common side effects include hypoglycemia, allergic reactions, and injection site reactions.

Humulin 70/30 (Premixed Insulin):

• Pharmacokinetics:
  • Onset: Begins to work within 10 to 20 minutes after injection.
  • Peak: Peaks in 2 to 12 hours.
  • Duration: Lasts up to 18 to 24 hours.
• Uses: Humulin 70/30 is a mixture of 70% NPH insulin and 30% regular insulin. It is used to provide both mealtime and basal insulin coverage in a single injection.
• Benefits: Simplifies the insulin regimen by combining two types of insulin in one injection.
• Side Effects: Common side effects include hypoglycemia, allergic reactions, and injection site reactions.

Comparing Tresiba and Humulin

Duration of Action:

• Tresiba: Ultra-long-acting, up to 42 hours.
• Humulin: Varies by formulation. Humulin R (up to 8 hours), Humulin N (up to 18 hours), Humulin 70/30 (up to 24 hours).

Dosing Frequency:

• Tresiba: Once daily.
• Humulin: Humulin R is typically taken multiple times daily with meals. Humulin N is taken once or twice daily. Humulin 70/30 is taken one to two times daily.

Flexibility:

• Tresiba: High flexibility due to long duration and no pronounced peak.
• Humulin: Less flexibility, especially with Humulin R, which requires precise timing around meals.

Risk of Hypoglycemia:

• Tresiba: Lower risk due to steady insulin release.
• Humulin: Higher risk, particularly with Humulin R and N, which have pronounced peaks.

Patient Suitability:

• Tresiba: Ideal for patients needing flexible dosing and those prone to hypoglycemia.
• Humulin: Suitable for patients who can adhere to a stricter dosing schedule and require tailored insulin regimens.

Clinical Studies and Efficacy

Numerous clinical studies have compared the efficacy and safety of Tresiba and Humulin.

Tresiba Studies:

• A study published in “Diabetes Care” compared Tresiba with insulin glargine in Type 1 diabetes patients. The results showed similar HbA1c reductions but a significantly lower rate of nocturnal hypoglycemia with Tresiba.
• Another study in “The Lancet Diabetes & Endocrinology” examined Type 2 diabetes patients. Tresiba demonstrated superior fasting blood glucose control and reduced hypoglycemic events compared to insulin glargine.

Humulin Studies:

• Research in the “Journal of Diabetes Science and Technology” highlighted the efficacy of Humulin R in managing postprandial glucose levels. The study found it effective when used in a mealtime regimen.
• A study in “Diabetes, Obesity, and Metabolism” compared Humulin N with other intermediate-acting insulins. Humulin N provided effective basal insulin coverage but had a higher risk of hypoglycemia compared to long-acting insulins.

Practical Considerations

Cost:

• The cost of insulin can be a significant factor in deciding which type to use. Tresiba, being a newer insulin, is generally more expensive than Humulin formulations. However, its benefits in terms of flexibility and reduced hypoglycemia may justify the higher cost for some patients.

Insurance Coverage:

• Insurance coverage varies by provider and plan. Patients should check with their insurance company to understand the coverage and out-of-pocket costs for Tresiba and Humulin.

Storage:

• Tresiba and Humulin should be stored in a refrigerator until opened. Once in use, they can be kept at room temperature but must be used within a specified period. Tresiba can be used for up to 8 weeks after opening, while Humulin R, N, and 70/30 typically need to be used within 28 days.

Injection Devices:

• Tresiba is available in prefilled FlexTouch pens, making it convenient for patients to administer. Humulin is available in vials and prefilled KwikPens. The choice of device may influence patient preference and adherence.

Lifestyle Considerations:

• Patients with irregular schedules or those who travel frequently may benefit more from Tresiba’s flexible dosing. In contrast, patients with a consistent daily routine may find Humulin’s regimen manageable.

Conclusion

Choosing between Tresiba and Humulin depends on various factors, including the patient’s lifestyle, the need for flexibility, the risk of hypoglycemia, and cost considerations. Tresiba offers the advantage of once-daily dosing with a lower risk of hypoglycemia, making it ideal for patients needing flexibility in their insulin regimen. Humulin, with its different formulations, provides tailored options for mealtime and basal insulin needs but requires a stricter dosing schedule.

Ultimately, the decision should be made in consultation with a healthcare provider who can consider individual patient needs and preferences. Whether you opt for Tresiba or Humulin, effective diabetes management is key to maintaining good health and preventing complications.

Buy Insulin Medications from US Script Care

For those in need of insulin medications, consider purchasing from US Script Care, an online pharmacy partner known for providing affordable and reliable medications. US Script Care offers a wide range of insulin products, ensuring that you can find the right medication for your diabetes management needs. With convenient online ordering and delivery services, managing your diabetes has never been easier.